Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis-Reference-Cited by-同舟云学术

Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis

Published:2018-12-13 Issue: Volume:8 Page:
ISSN:2235-2988
Container-title:Frontiers in Cellular and Infection Microbiology
language:
Short-container-title:Front. Cell. Infect. Microbiol.

Author:

Marlais Tegwen,Bhattacharyya Tapan,Singh Om Prakash,Mertens Pascal,Gilleman Quentin,Thunissen Caroline,Hinckel Bruno C. Bremer,Pearson Callum,Gardner Bathsheba L.,Airs Stephanie,de la Roche Marianne,Hayes Kiera,Hafezi Hannah,Falconar Andrew K.,Eisa Osama,Saad Alfarazdeg,Khanal Basudha,Bhattarai Narayan Raj,Rijal Suman,Boelaert Marleen,El-Safi Sayda,Sundar Shyam,Miles Michael A.

Funder

Sir Halley Stewart Trust

Seventh Framework Programme

H2020 Marie Skłodowska-Curie Actions

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference54 articles.

1. Heterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions;Abass;PLoS ONE,2015

2. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan;Atia;Trop. Med. Int. Health,2015

3. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village;Bern;Am. J. Trop. Med. Hyg.,2007